Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Breen Michael Martin Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Breen Michael Martin (Executive Chairman/Interim CEO) has filed a Form 4 on GT Biopharma, Inc.
Txns: Granted 200,000 shares @ $0.287, valued at $57.4k
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/12/2021 4 Breen Michael Martin (Director) has filed a Form 4 on GT Biopharma, Inc.
Txns: Converted 100,000 options to buy @ $3.4, valued at $340k
Converted 30,000 options to buy @ $3.4, valued at $102k
Granted 278,058 shares @ $0
Converted 40,243 shares @ $3.4, valued at $136.8k
Converted 9,859 shares @ $3.4, valued at $33.5k
Granted 50,000 options to buy @ $6.33, valued at $316.5k
11/12/2021 3 Breen Michael Martin (Director) has filed a Form 3 on GT Biopharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy